25.6.2004 |
EN |
Official Journal of the European Union |
C 166/2 |
Summary of Community decisions on marketing authorizations in respect of medicinal products from 15/05/2004 to 15/06/2004
(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)
(2004/C 166/02)
Issuing of a marketing authorization (Article 12 of Council Regulation (EEC) No 2309/93) Accepted
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
||||||
01.06.2004 |
Levemir |
|
EU/01/04/278/001-009 |
04.06.2004 |
||||||
04.06.2004 |
Abilifly |
|
EU/1/04/276/001-020 |
08.06.2004 |
||||||
08.06.2004 |
TachoSil |
|
EU/1/04/277/001-004 |
11.06.2004 |
||||||
15.06.2004 |
Oxybutynin |
|
EU/1/03/270/001-002 |
18.06.2004 |
Modification of a marketing authorization (Article 12 of Council Regulation (EEC) No 2309/93) Accepted
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|||||
19.05.2004 |
Protopic |
|
EU/1/02/201/001-006 |
25.05.2004 |
|||||
25.05.2004 |
Hepsera |
|
EU/1/03/251/001 |
27.05.2004 |
|||||
26.05.2004 |
Viagra |
|
EU/1/98/077/001-012 |
01.06.2004 |
|||||
26.05.2004 |
Combivir |
|
EU/1/98/058/001-002 |
01.06.2004 |
|||||
26.05.2004 |
Ziagen |
|
EU/1/99/112/001-002 |
01.06.2004 |
|||||
26.05.2004 |
Taxotere |
|
EU/1/95/002/001-002 |
01.06.2004 |
|||||
26.05.2004 |
TRIZIVIR |
|
EU/1/00/156/001-003 |
01.06.2004 |
|||||
01.06.2004 |
Vivanza |
|
EU/1/03/249/001-012 |
07.06.2004 |
|||||
01.06.2004 |
Levitra |
|
EU/1/03/248/001-012 |
07.06.2004 |
|||||
01.06.2004 |
Epivir |
|
EU/1/96/015/001-005 |
07.06.2004 |
|||||
08.06.2004 |
Remicade |
|
EU/1/99/116/001-003 |
10.06.2004 |
|||||
08.06.2004 |
Remicade |
|
EU/1/99/116/001-003 |
10.06.2004 |
|||||
08.06.2004 |
Fuzeon |
|
EU/1/03/252/001-003 |
10.06.2004 |
|||||
08.06.2004 |
Arava |
|
EU/1/99/118/001-010/ |
18.06.2004 |
|||||
08.06.2004 |
Vfend |
|
EU/1/02/212/001-026 |
10.06.2004 |
|||||
09.06.2004 |
Vfend |
|
EU/1/02/212/001-026 |
11.06.2004 |
|||||
10.06.2004 |
Arava |
|
EU/1/99/118/001-010/ |
16.06.2004 |
|||||
10.06.2004 |
Viread |
|
EU/1/01/200/001 |
14.06.2004 |
|||||
10.06.2004 |
Viread |
|
EU/1/01/200/001 |
15.06.2004 |
|||||
10.06.2004 |
Herceptin |
|
EU/1/00/145/001 |
14.06.2004 |
|||||
10.06.2004 |
Humira |
|
EU/1/03/256/001-006 |
14.06.2004 |
|||||
10.06.2004 |
Trudexa |
|
EU/1/03/257/001-006 |
14.06.2004 |
|||||
15.06.2004 |
Xigris |
|
EU/1/02/225/001-002 |
17.06.2004 |